Table 1. Sustained Response During Weeks 18-36 for Patients who had not Achieved Sustained Response by Week 12.

Treatment Arm	Number (%) of Patients who had not Achieved Sustained Response by Week 12	Week 18-36 Sustained Response Status	n (%)
COMB	25 of 86 (29.1%)	Sustained Response Possible Sustained Response Non-Sustained Response	15 (60.0%) 5 (20.0%) 5 (20.0%)
FLX	26 of 80 (32.5%)	Sustained Response Possible Sustained Response Non-Sustained Response	12 (46.2%) 4 (15.4%) 10 (38.5%)
CBT	44 of 76 (57.9%)	Sustained Response Possible Sustained Response Non-Sustained Response	25 (56.8%) 9 (20.5%) 10 (22.7%)
All Active Tx	95 of 242 (39.3%)	Sustained Response Possible Sustained Response Non-Sustained Response	52 (54.7%) 18 (18.9%) 25 (26.3%)

Note: Week 18-36 Sustained Response Status indicates whether the patient achieved Sustained Response at any point during the period. If the patient had multiple response classifications across the period, the best response status was counted. The clinical ordering of response status from best to worse is: Sustained Response (i.e., 2 consecutive ratings of “full responder,” defined as CGI-I = 1 or 2), Possible Sustained Response (i.e., one rating of “full responder” either at the end of Stage III or followed by missing assessments only), and Non-Sustained Response (all other responder patterns).